0001646343-16-000010.txt : 20161114 0001646343-16-000010.hdr.sgml : 20161111 20161114160819 ACCESSION NUMBER: 0001646343-16-000010 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161114 DATE AS OF CHANGE: 20161114 EFFECTIVENESS DATE: 20161114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEXTHERA CAPITAL LP CENTRAL INDEX KEY: 0001646343 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-17280 FILM NUMBER: 161994868 BUSINESS ADDRESS: STREET 1: 900 THIRD AVENUE STREET 2: SUITE 1100 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 213-7033 MAIL ADDRESS: STREET 1: 900 THIRD AVENUE STREET 2: SUITE 1100 CITY: NEW YORK STATE: NY ZIP: 10022 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001646343 XXXXXXXX 09-30-2016 09-30-2016 NEXTHERA CAPITAL LP

900 THIRD AVENUE SUITE 1100 NEW YORK NY 10022

13F HOLDINGS REPORT 028-17280 N Daniel Malek 6462137030 Daniel Malek New York NY 11-14-2016 0 33 162735 false INFORMATION TABLE 2 NEXTHERA_Q3_13F_FILING.xml Abeona Therapeutics Inc COM 00289Y107 1930 321609 SH SOLE 321609 0 0 Acceleron Pharma Inc COM 00434H108 7883 217817 SH SOLE 217817 0 0 Adamas Pharmaceuticals Inc COM 00548A106 4574 278740 SH SOLE 278740 0 0 Advaxis Inc COM NEW 007624208 2138 200000 SH SOLE 200000 0 0 Aerie Pharmaceuticals Inc COM 00771V108 1887 50000 SH SOLE 50000 0 0 Aquinox Pharmaceuticals Inc COM 03842B101 4542 340000 SH SOLE 340000 0 0 Ascendis Pharma A/S SPONSORED ADR 04351P101 2939 146200 SH SOLE 146200 0 0 AstraZeneca PLC CALL 046353908 8215 250000 SH Call SOLE 250000 0 0 Axovant Sciences Ltd COM G0750W104 1400 100000 SH SOLE 100000 0 0 BioPharmX Corp COM 09072X101 32 57656 SH SOLE 57656 0 0 Clovis Oncology Inc COM 189464100 4326 120000 SH SOLE 120000 0 0 CoLucid Pharmaceuticals Inc COM 19716T101 3815 100000 SH SOLE 100000 0 0 Concert Pharmaceuticals Inc COM 206022105 1697 167866 SH SOLE 167866 0 0 Eiger BioPharmaceuticals Inc COM 28249U105 3535 264000 SH SOLE 264000 0 0 FibroGen Inc COM 31572Q808 2643 127680 SH SOLE 127680 0 0 Foamix Pharmaceuticals Ltd SHS M46135105 1158 125000 SH SOLE 125000 0 0 GlaxoSmithKline PLC SPONSORED ADR 37733W105 14880 345000 SH SOLE 345000 0 0 Immune Design Corp COM 45252L103 2312 305000 SH SOLE 305000 0 0 Immunomedics Inc COM 452907108 4106 1263276 SH SOLE 1263276 0 0 Insmed Inc COM PAR $.01 457669307 4676 322044 SH SOLE 322044 0 0 Lannett Co Inc COM 516012101 4437 167000 SH SOLE 167000 0 0 Neuroderm Ltd ORD SHS M74231107 2422 131000 SH SOLE 131000 0 0 Ophthotech Corp COM 683745103 1107 24000 SH SOLE 24000 0 0 Pfizer Inc COM 717081103 22153 654051 SH SOLE 654051 0 0 Progenics Pharmaceuticals Inc COM 743187106 2216 350000 SH SOLE 350000 0 0 Seattle Genetics Inc COM 812578102 6022 111500 SH SOLE 111500 0 0 Shire PLC SPONSORED ADR 82481R106 12989 67000 SH SOLE 67000 0 0 SPDR S&P Biotech ETF PUT 78464A950 26516 400000 SH Put SOLE 400000 0 0 Trevena Inc COM 89532E109 2017 298849 SH SOLE 298849 0 0 Vascular Biogenics Ltd COM M96883109 174 33332 SH SOLE 33332 0 0 Verastem Inc COM 92337C104 447 336000 SH SOLE 336000 0 0 VistaGen Therapeutics Inc COM NEW 92840H202 575 138132 SH SOLE 138132 0 0 Zogenix Inc COM NEW 98978L204 2972 260000 SH SOLE 260000 0 0